| Short Description : | Recombinant-Human HIV-1 gp160-protein was developed from. For use in research applications. |
| Note: | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | 0.2 µm filtered 100mM PBS, pH4.5, 10mM tris HCL., 300mM Imidiasole, 8M Urea |
| Storage Instruction: | Can be stored in working aliquots at 4°C C for one month, or at-20°C C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin: | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg (1EU/µg). NA |
| Immunogen: | Recombinant HIV gp160 encodes the immunodominant sequences of the HIV Transmembrane Glycoprotein 160. NA |
| Specificity: | Immunoreative with sera of infected HIV individuals |
| Background | Recombinant HIV gp160 is fused to an Beta-galactosidase purification tag and migrates as 58kDa on PAGE. |
Information sourced from Uniprot.org